© Drug Hunter Inc. 2018-2023
Home > WF-47-JS03
RET kinase inhibitor
orally efficacious in XG but narrow TI
from data mining of internal matter and opt.
ACS Med. Chem. Lett. Feb. 12, 2020
Novartis (GNF), San Diego, CA
(Novartis (GNF) oral in vivo RET kinase inhibitor)
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.
Molecules of the Month
Molecule of the Year